Patent Assignment
Reel/Frame 065610/0902
Release of Patent Security Interests Recorded at Reel 039237, Frame 0147
Recorded: 2023-11-16
Pages: 43
Assignor
DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Executed: 2023-11-14
Assignees
MALLINCKRODT INTERNATIONAL FINANCE S.A.
124 BOULEVARD DE LA PETRUSSE, L-2330 LUXEMBOURG, LUXEMBOURG
MALLINCKRODT CB LLC
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 93042
MALLINCKRODT FINANCE GMBH
VICTOR VON BRUNS-STRASSE 19, 8212 NEUHAUSEN AM RHEINFALL, SWITZERLAND
MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
MALLINCKRODT CARRIBEAN, INC.
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
MALLINCKRODT US POOL LLC
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
MNK 2011 LLC (F/K/A MALLINCKRODT INC.)
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
LUDLOW LLC (F/K/A LUDLOW CORPORATION)
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
CNS THERAPEUTICS, INC.
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.)
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
MALLINCKRODT ENTERPRISES LLC
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
MALLINCKRODT LLC
385 MARSHALL AVENUE, WEBSTER GROVES, MISSOURI, 63119
LAFAYETTE PHARMACEUTICALS LLC
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
LIEBEL-FLARSHEIM COMPANY LLC
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.)
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
MALLINCKRODT VETERINARY, INC.
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
MALLINCKRODT US HOLDINGS LLC
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
IMC EXPLORATION COMPANY
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
MEH, INC.
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED)
COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN, DUBLIN 15, IRELAND
MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED)
COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN, DUBLIN 15, IRELAND
OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.)
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
SPECGX LLC
385 MARSHALL AVENUE, WEBSTER GROVES, MISSOURI, 63119
STRATATECH CORPORATION
510 CHARMANY DR. NO. 169, MADISON, WISCONSIN, 53719
SUCAMPO PHARMA AMERICAS LLC
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
VTESSE LLC (F/K/A VTESSE INC.)
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN, DUBLIN 15, IRELAND
MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.)
COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN, DUBLIN 15, IRELAND
INFACARE PHARMACEUTICAL CORPORATION
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
ST SHARED SERVICES LLC
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
THERAKOS, INC.
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
IKARIA THERAPEUTICS LLC
53 FRONTAGE ROAD, THIRD FLOOR, HAMPTON, NEW JERSEY, 08827
INO THERAPEUTICS LLC
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
Covered Properties
(49)
Extended Release Compositions Comprising Hydrocodone And Acetaminophen For Rapid Onset And Prolonged Analgesia That May Be Administered Without Regard To Food
Application:
14/187,939 →
Publication:
US 2014/0288113
Suspicious Order Monitoring System and Method
Patent:
10,089,678 →
Application:
14/192,971 →
Liposome Oxaliplatin Compositions for Cancer Therapy
Application:
14/207,260 →
Publication:
US 2014/0271820
Liposomal Cisplatin Compositions for Cancer Therapy
Modified Docetaxel Liposome Formulations
Application:
14/208,324 →
Publication:
US 2014/0271822
Matrix Metalloprotease (Mmp) Targeted Agents for Imaging and Therapy
Application:
14/208,350 →
Publication:
US 2014/0271465
Abuse Deterrent Solid Dosage Form for Immediate Release with Functional Score
Purification of Metals
Gastric Retentive Extended Release Pharmaceutical Compositions
Process and Apparatus for Treating a Gas Stream
Process of Generating Germanium
Compounds and Compositions for Use in Phototherapy and in Treatment of Ocular Neovascular Disease and Cancers
Compounds and Compositions for Use in Phototherapy and in Treatment of Ocular Neovascular Disease and Cancers
Self-Aligning Radioisotope Elution System and Method
Method and Apparatus for Disposal of a Pharmaceutical Product Blister Card
Application:
14/336,357 →
Publication:
US 2014/0331610
Remote Assembly of Targeted Nanoparticles Using Complementary Oligonucleotide Linkers
Application:
14/348,522 →
Publication:
US 2014/0234217
Hand-Actuated Fluid Delivery Device
Application:
14/357,644 →
Publication:
US 2014/0291355
Hand-Actuated Fluid Delivery Device Having Triggered Lock for Selectively Limiting Automatic Aspiration Stroke
Application:
14/358,061 →
Publication:
US 2014/0323984
Version of Fdg Detectable by Single-Photon Emission Computed Tomography
Tamper Resistant Composition Comprising Hydrocodone And Acetaminophen For Rapid Onset And Extended Duration Of Analgesia
Pharmaceutical Product Container with Permanent Locking Mechanism
Mmp-Targeted Therapeutic and/or Diagnostic Nanocarriers
Application:
14/490,357 →
Publication:
US 2015/0004097
PROCESS FOR THE PREPARATION OF RADIOIODINATED 3-FLUOROPROPYL-NOR-Beta-CIT
Processes For Preparing Morphinan-6-One Products With Low Levels Of Alpha, Beta-Unsaturated Ketone Compounds
Application:
14/504,750 →
Publication:
US 2015/0148365
Substituted Berbines and Their Synthesis
Nanoparticle Peg Modification with H-Phosphonates
Application:
14/513,994 →
Publication:
US 2015/0030541
Systems and Methods for Assaying an Eluate for Technetium and Molybdenum Content
Convenient Preparation of N-Substituted Morphinan-6-Ols from Morphinan-6-Ones
Production of 6-Hydroxy Morphinans Without the Isolation of Intermediates
Preparation of Normorphinans
Process for the Preparation of Quaternary N-Alkyl Morphinan Alkaloid Salts
Intrathecal Baclofen Pharmaceutical Dosage Forms with Fewer Degradation Products
Combination Composition Comprising Oxycodone and Acetaminophen for Rapid Onset and Extended Duration of Analgesia
Medicament Sachet Leak Testing System
Pharmaceutical Compositions for Extended Release of Oxycodone and Acetaminophen Resulting in a Quick Onset and Prolonged Period of Analgesia
Sealable Secondary Packaging for Pharmaceutical Product Blister Pack
Spray Dried Compositions Having Different Dissolution Profiles and Processes for Their Preparation
Intrathecal Baclofen Pharmaceutical Dosage Forms and Related Delivery System
Application:
14/725,714 →
Publication:
US 2015/0258279
Oxidative Dearomatization of Berbines
Abuse Deterrent Immediate Release Formulations Comprising Non-Cellulose Polysaccharides
Process for Preparing Substituted Phenylalkanes
(+)-Morphinans as Antagonists of Toll-Like Receptor 9 and Therapeutic Uses Thereof
Stability of Hydromorphone Hydrochloride Solutions
Application:
14/834,536 →
Publication:
US 2015/0359790
Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans
Application:
14/921,188 →
Publication:
US 2016/0184232
Modified Docetaxel Liposome Formulations and Uses Thereof
Application:
62/117,299 →
Modified Docetaxel Liposome Formulations and Uses Thereof
Application:
62/148,549 →
Preparation of Sufentanil Citrate and Sufentanil Base
Application:
62/166,911 →
Two-Step Process for Preparing 3-Substituted Phenylalkylamines
Application:
62/190,975 →
Stability of Liposome Formulations and Uses Thereof
Application:
62/221,244 →
Related Assignments
(13)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 23, 2016
From: DEVARAKONDA, KRISHNA; GIULIANI, MICHAEL J.; GUPTA, VISHAL K.; HEASLEY, RALPH A.
To: MALLINCKRODT LLC
Reel/Frame 040410/0924 →
Release of Security Interest
Jan 31, 2017
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: MALLINCKRODT NUCLEAR MEDICINE LLC
Reel/Frame 041131/0213 →
Assignment of Assignor's Interest
Dec 13, 2017
From: MALLINCKRODT LLC
To: SPECGX LLC
Reel/Frame 044891/0376 →
Security Interest
Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
Release of Security Interest
Jun 17, 2022
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS, INC.; MALLINCKRODT LLC; MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED)
Reel/Frame 060389/0839 →
Security Interest
Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
Notice of Grant of Security Interest in Intellectual Property
Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
Change of Name
Apr 3, 2023
From: MALLINCKRODT NUCLEAR MEDICINE LLC
To: CURIUM US LLC
Reel/Frame 063240/0591 →
Security Interest
Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
Release of Security Interests in Patents at Reel 060389/Frame 0913
Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
Reel/Frame 065583/0465 →
Release of Patent Security Interests Recorded at Reel 060434, Frame 0536
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
Reel/Frame 065601/0347 →
Intellectual Property Security Agreement
Jul 31, 2025
From: SPECGX LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 072313/0063 →
Release of Security Interest
Aug 14, 2025
From: ACQUIOM AGENCY SERVICES LLC
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 072324/0740 →